Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-23
DOI
10.3389/fimmu.2017.01355
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New development in CAR-T cell therapy
- (2017) Zhenguang Wang et al. Journal of Hematology & Oncology
- Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma
- (2017) Laura Escribà-Garcia et al. Journal of Translational Medicine
- Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
- (2017) Dominique Bollino et al. Translational Research
- Enhancement of Adjuvant Functions of Natural Killer T Cells Using Nanovector Delivery Systems: Application in Anticancer Immune Therapy
- (2017) Reem Ghinnagow et al. Frontiers in Immunology
- Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression
- (2016) P Guan et al. BONE MARROW TRANSPLANTATION
- Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival
- (2016) Sarah Oelsner et al. INTERNATIONAL JOURNAL OF CANCER
- CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
- (2016) Gengwen Tian et al. JOURNAL OF CLINICAL INVESTIGATION
- NKG2D–NKG2D Ligand Interaction Inhibits the Outgrowth of Naturally Arising Low-Grade B Cell Lymphoma In Vivo
- (2016) Saravanan Raju et al. JOURNAL OF IMMUNOLOGY
- The Rho-ROCKpathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia
- (2016) Sara Basbous et al. JOURNAL OF PATHOLOGY
- Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies
- (2016) Yun Luo et al. LEUKEMIA RESEARCH
- Lactic acid in tumor microenvironments causes dysfunction of NKT cells by interfering with mTOR signaling
- (2016) Di Xie et al. Science China-Life Sciences
- Efficient Regeneration of Human Vα24+Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
- (2016) Daisuke Yamada et al. STEM CELLS
- CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells
- (2016) Nadja Zaborsky et al. Oncotarget
- Applications of nanoparticles for diagnosis and therapy of cancer
- (2015) S C Baetke et al. BRITISH JOURNAL OF RADIOLOGY
- Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors
- (2015) S. Lu et al. CLINICAL CANCER RESEARCH
- Lenalidomide expand CD3+CD56+ T cell cytokine induced killer (CIK) cells in vivo in multiple myeloma patients
- (2015) H. Handa et al. Clinical Lymphoma Myeloma & Leukemia
- Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional
- (2015) Wenji Sun et al. CYTOKINE
- Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma
- (2015) Lena Belting et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis
- (2015) F. Wein et al. HAEMATOLOGICA
- Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis
- (2015) F. Wein et al. HAEMATOLOGICA
- The Regulatory Role of Invariant NKT Cells in Tumor Immunity
- (2015) Rosanna M. McEwen-Smith et al. Cancer Immunology Research
- Recognition of Microbial Glycolipids by Natural Killer T Cells
- (2015) Dirk M. Zajonc et al. Frontiers in Immunology
- Combinatorial Strategies for the Induction of Immunogenic Cell Death
- (2015) Lucillia Bezu et al. Frontiers in Immunology
- NKT cell-targeted vaccination plus anti-4–1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma
- (2015) Takumi Kobayashi et al. OncoImmunology
- Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
- (2015) Yusuf Dölen et al. OncoImmunology
- Lymphoma: Immune Evasion Strategies
- (2015) Ranjan Upadhyay et al. Cancers
- An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
- (2014) J. D. Gibbins et al. BLOOD
- Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
- (2014) A. Heczey et al. BLOOD
- Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
- (2014) Frederic Schmeel et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
- (2014) Leonard Christopher Schmeel et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role and Regulation of CD1d in Normal and Pathological B Cells
- (2014) Mohammed S. Chaudhry et al. JOURNAL OF IMMUNOLOGY
- Targeted Delivery of α-Galactosylceramide to CD8α+Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses
- (2014) Elodie Macho-Fernandez et al. JOURNAL OF IMMUNOLOGY
- CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia
- (2014) WENJIAN GUO et al. Oncology Letters
- Invariant NKT cells
- (2014) Hamid Bassiri et al. OncoImmunology
- Lipid antigens in immunity
- (2013) C. Marie Dowds et al. BIOLOGICAL CHEMISTRY
- Synergistic Induction of Adaptive Antitumor Immunity by Codelivery of Antigen with α-Galactosylceramide on Exosomes
- (2013) Ulf Gehrmann et al. CANCER RESEARCH
- Natural killer T cell defects in multiple myeloma and the impact of lenalidomide therapy
- (2013) A. C. Chan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD3+/CD16+CD56+ cell numbers in peripheral blood are correlated with higher tumor burden in patients with diffuse large B-cell lymphoma
- (2013) Iwona Hus et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy
- (2013) R. Weinkove et al. HAEMATOLOGICA
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
- (2013) Sungyoul Hong et al. IMMUNOLOGY LETTERS
- The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
- (2013) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- CD1d expression as a prognostic marker for chronic lymphocytic leukemia
- (2013) Athanasios Anastasiadis et al. LEUKEMIA & LYMPHOMA
- CD1d expression is higher in chronic lymphocytic leukemia patients with unfavorable prognosis
- (2013) Agnieszka Bojarska-Junak et al. LEUKEMIA RESEARCH
- Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
- (2013) Haneen Nur et al. PLoS One
- Immune evasion in acute myeloid leukemia: current concepts and future directions
- (2013) Ryan M Teague et al. Journal for ImmunoTherapy of Cancer
- NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
- (2012) S. R. Mattarollo et al. BLOOD
- Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma
- (2012) J. Richter et al. BLOOD
- Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
- (2012) Alexis Rossignol et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Low number of invariant NKT cells is associated with poor survival in acute myeloid leukemia
- (2012) Alicia E. Najera Chuc et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells
- (2012) Kaoru Nagato et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity
- (2012) Daofeng Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating Invariant Natural Killer T-Cell Numbers Predict Outcome in Head and Neck Squamous Cell Carcinoma: Updated Analysis With 10-Year Follow-Up
- (2012) Famke L. Schneiders et al. JOURNAL OF CLINICAL ONCOLOGY
- Virus-like particles and α-galactosylceramide form a self-adjuvanting composite particle that elicits anti-tumor responses
- (2012) Sara J. McKee et al. JOURNAL OF CONTROLLED RELEASE
- Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
- (2012) J. Hilpert et al. JOURNAL OF IMMUNOLOGY
- Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia
- (2012) Farhad Jadidi-Niaragh et al. MEDICAL ONCOLOGY
- Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL
- (2012) Kumiko Kagawa et al. PLoS One
- Invariant natural killer T cells reconstitution and the control of leukemia relapse in pediatric haploidentical hematopoietic stem cell transplantation
- (2012) Giulia Casorati et al. OncoImmunology
- The Diagnostic Value of CD1d Expression in a Large Cohort of Patients With B-Cell Chronic Lymphoproliferative Disorders
- (2011) Ioannis Kotsianidis et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants
- (2011) D. Hongo et al. BLOOD
- High ERp5/ADAM10 expression in lymph node microenvironment and impaired NKG2D ligands recognition in Hodgkin lymphomas
- (2011) M. R. Zocchi et al. BLOOD
- Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer
- (2011) Shinichiro Motohashi et al. CLINICAL IMMUNOLOGY
- NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d
- (2011) Carlotta Kuylenstierna et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Natural killer cell subsets and natural killer–like T-cell populations in benign and neoplastic B-cell proliferations vary based on clinicopathologic features
- (2011) Sarah E. Gibson et al. HUMAN PATHOLOGY
- Invariant NKT Cell Reconstitution in Pediatric Leukemia Patients Given HLA-Haploidentical Stem Cell Transplantation Defines Distinct CD4 + and CD4 − Subset Dynamics and Correlates with Remission State
- (2011) Claudia de Lalla et al. JOURNAL OF IMMUNOLOGY
- High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2
- (2011) M.E.D. Chamuleau et al. LEUKEMIA RESEARCH
- The stimulating adventure of KRN 7000
- (2011) Aline Banchet-Cadeddu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis
- (2011) Laura M. Hix et al. PLoS One
- Expression of CD1d and presence of invariant NKT cells in classical Hodgkin lymphoma
- (2010) Chuanhui Xu et al. AMERICAN JOURNAL OF HEMATOLOGY
- Pharmacologic Expansion of Donor-Derived, Naturally Occurring CD4+Foxp3+ Regulatory T Cells Reduces Acute Graft-versus-Host Disease Lethality Without Abrogating the Graft-versus-Leukemia Effect in Murine Models
- (2010) Omar Duramad et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Mechanisms of tumor growth retardation by modulation of pH regulation in the tumor-microenvironment of a murine T cell lymphoma
- (2010) Naveen Kumar Vishvakarma et al. BIOMEDICINE & PHARMACOTHERAPY
- On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies
- (2010) Paolo Dellabona et al. CLINICAL IMMUNOLOGY
- Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection
- (2010) Famke L. Schneiders et al. CLINICAL IMMUNOLOGY
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- TRAIL/TRAIL-R in hematologic malignancies
- (2010) Ugo Testa JOURNAL OF CELLULAR BIOCHEMISTRY
- Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95/CD178-Dependent and Is Correlated with Antigenic Potency
- (2010) G. Wingender et al. JOURNAL OF IMMUNOLOGY
- The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
- (2010) H Nückel et al. LEUKEMIA
- Defective NKT Cell Activation by CD1d+ TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide
- (2010) Michael Nowak et al. PLoS One
- Type I natural killer T cells suppress tumors caused by p53 loss in mice
- (2009) J. B. Swann et al. BLOOD
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms
- (2009) D. Bagnara et al. HAEMATOLOGICA
- Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells
- (2009) Tonya J. Webb et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
- (2009) A Poggi et al. LEUKEMIA
- Identification of iGb3 and iGb4 in melanoma B16F10-Nex2 cells and the iNKT cell-mediated antitumor effect of dendritic cells primed with iGb3
- (2009) Bianca R Dias et al. Molecular Cancer
- Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
- (2009) Prakash Thapa et al. VACCINE
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
- (2008) D. H. Chang et al. BLOOD
- Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma
- (2008) G. J. Renukaradhya et al. BLOOD
- Generation of Antitumor Invariant Natural Killer T Cell Lines in Multiple Myeloma and Promotion of Their Functions via Lenalidomide: A Strategy for Immunotherapy
- (2008) W. Song et al. CLINICAL CANCER RESEARCH
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Tumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
- (2008) H WANG et al. IMMUNOLOGY LETTERS
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now